Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection

Antonio Mur; Veronica Seidel; María Ángeles López-Vilchez; Mariona Bonet; Montserrat Gilaberte

doi:10.1097/01.inf.0000172936.20623.fd

Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection

Antonio Mur, Veronica Seidel, María Ángeles López-Vilchez, Mariona Bonet, Montserrat Gilaberte

Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine and Public Health

Research output: Contribution to journal › Article › Research › peer-review

8 Citations (Scopus)

Abstract

We report an 11-year-old girl with acanthosis nigricans that appeared after 4 years of treatment with didanosine, stavudine and amprenavir. Laboratory studies showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia. Withdrawal of amprenavir resulted in disappearance of acanthosis nigricans and improvement of metabolic abnormalities. © 2005 Lippincott Williams & Wilkins.

Original language	English
Pages (from-to)	742-743
Journal	Pediatric Infectious Disease Journal
Volume	24
Issue number	8
DOIs	https://doi.org/10.1097/01.inf.0000172936.20623.fd https://doi.org/10.1097/01.inf.000172936.20623.fd
Publication status	Published - 1 Aug 2005

Keywords

acanthosis nigricans
antiretroviral therapy
Human immunodeficiency virus infection

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

Mur, A., Seidel, V., López-Vilchez, M. Á., Bonet, M., & Gilaberte, M. (2005). Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection. Pediatric Infectious Disease Journal, 24(8), 742-743. https://doi.org/10.1097/01.inf.0000172936.20623.fd, https://doi.org/10.1097/01.inf.000172936.20623.fd

@article{358201744b6e436f8fd18740145d705a,

title = "Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection",

abstract = "We report an 11-year-old girl with acanthosis nigricans that appeared after 4 years of treatment with didanosine, stavudine and amprenavir. Laboratory studies showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia. Withdrawal of amprenavir resulted in disappearance of acanthosis nigricans and improvement of metabolic abnormalities. {\textcopyright} 2005 Lippincott Williams & Wilkins.",

keywords = "acanthosis nigricans, antiretroviral therapy, Human immunodeficiency virus infection",

author = "Antonio Mur and Veronica Seidel and L{\'o}pez-Vilchez, {Mar{\'i}a {\'A}ngeles} and Mariona Bonet and Montserrat Gilaberte",

year = "2005",

month = aug,

day = "1",

doi = "10.1097/01.inf.0000172936.20623.fd",

language = "English",

volume = "24",

pages = "742--743",

number = "8",

}

Mur, A, Seidel, V, López-Vilchez, MÁ, Bonet, M & Gilaberte, M 2005, 'Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection', Pediatric Infectious Disease Journal, vol. 24, no. 8, pp. 742-743. https://doi.org/10.1097/01.inf.0000172936.20623.fd, https://doi.org/10.1097/01.inf.000172936.20623.fd

Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection. / Mur, Antonio; Seidel, Veronica; López-Vilchez, María Ángeles et al.

In: Pediatric Infectious Disease Journal, Vol. 24, No. 8, 01.08.2005, p. 742-743.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection

AU - Mur, Antonio

AU - Seidel, Veronica

AU - López-Vilchez, María Ángeles

AU - Bonet, Mariona

AU - Gilaberte, Montserrat

PY - 2005/8/1

Y1 - 2005/8/1

N2 - We report an 11-year-old girl with acanthosis nigricans that appeared after 4 years of treatment with didanosine, stavudine and amprenavir. Laboratory studies showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia. Withdrawal of amprenavir resulted in disappearance of acanthosis nigricans and improvement of metabolic abnormalities. © 2005 Lippincott Williams & Wilkins.

AB - We report an 11-year-old girl with acanthosis nigricans that appeared after 4 years of treatment with didanosine, stavudine and amprenavir. Laboratory studies showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia. Withdrawal of amprenavir resulted in disappearance of acanthosis nigricans and improvement of metabolic abnormalities. © 2005 Lippincott Williams & Wilkins.

KW - acanthosis nigricans

KW - antiretroviral therapy

KW - Human immunodeficiency virus infection

U2 - 10.1097/01.inf.0000172936.20623.fd

DO - 10.1097/01.inf.0000172936.20623.fd

M3 - Article

VL - 24

SP - 742

EP - 743

IS - 8

ER -

Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this